Summary

39.75 0.16(0.40%)07/16/2025
Legend Biotech Corporation (LEGN)

Key Facts


Historical Returns
1 Day1 Week1 Month3 Months6 Months1 Year5 Years
0.400.1010.9118.8026.47-28.8912.93


Price Chart Compare
Last 730 data points are shown. To view all data, Upgrade to PRO plan!


Fundamental Ratings
CategoryRating
Main RatingC-
Recommended RatingStrong Sell
DCFStrong Sell
ROEStrong Sell
ROAStrong Sell
Debt/EquitySell
P/EStrong Sell
P/BNeutral


Earnings
  • LEGN reported last earnings on 2025-05-13 after the market.
  • An EPS of $-0.07 was observed compared to an estimated EPS of $-0.4, resulting in a surprise value of $0.33.
  • A revenue of $195 million was observed compared to an estimated revenue of $218 million, resulting in a surprise value of $-23 Million.


    • Key Statistics
    Trading Data
    Close39.75
    Open41.00
    High41.00
    Low38.84
    Volume1,985,441
    Change0.16
    Change %0.40
    Avg Volume (20 Days)1,535,167
    Volume/Avg Volume (20 Days) Ratio1.29
    52 Week Range27.79 - 60.87
    Price vs 52 Week High-34.70%
    Price vs 52 Week Low43.04%
    Range0.00
    Gap Up/Down0.57
    Profitibility
    Market Capitalization (Mln)3,428
    Revenue per share3.9633
    Net Income per share-1.1871
    Dividend Yield0.0000
    Dividend Share0.00%
    Valuations
    Enterprise Value0.00%
    PE Ratio-16.7422
    PB Ratio0.0000
    PTB Ratio0.0000
    Liquidity
    Debt/Equity Ratio0.0000
    Net Debt/EBIDTA Ratio0.0000
    Current Ratio0.0000
    Enterprise Value and Cash Flow
    EV/Sales Ratio0.0000
    EV/EBIDTA Ratio0.0000
    EV/Free Cash Flow Ratio0.0000


    News
    06/11 07:30 EST - accessnewswire.com
    Legend Biotech Corporation INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Legend Biotech Corporation (LEGN)
    NEW YORK, NY / ACCESS Newswire / June 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Legend Biotech Corporation ("Legend Biotech Corporation") (NASDAQ:LEGN) concerning possible violations of federal securities laws. On May 13, 2024, Legend published first...
    06/10 07:30 EST - accessnewswire.com
    LEGN STOCK ALERT: Levi & Korsinsky Notifies Legend Biotech Corporation Investors of an Ongoing Investigation
    NEW YORK, NY / ACCESS Newswire / June 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Legend Biotech Corporation ("Legend Biotech Corporation") (NASDAQ:LEGN) concerning possible violations of federal securities laws. On May 13, 2024, Legend published first...
    06/09 07:30 EST - accessnewswire.com
    Shareholders That Lost Money on Legend Biotech Corporation (LEGN) Should Contact Levi & Korsinsky about Securities Fraud Investigation - LEGN
    NEW YORK, NY / ACCESS Newswire / June 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Legend Biotech Corporation ("Legend Biotech Corporation") (NASDAQ:LEGN) concerning possible violations of federal securities laws. On May 13, 2024, Legend published first...
    06/06 07:30 EST - accessnewswire.com
    Levi & Korsinsky Announces an Investigation on Behalf of Legend Biotech Corporation (LEGN) Shareholders Who May Have Been Affected by Fraud
    NEW YORK, NY / ACCESS Newswire / June 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Legend Biotech Corporation ("Legend Biotech Corporation") (NASDAQ:LEGN) concerning possible violations of federal securities laws. On May 13, 2024, Legend published first...
    06/05 07:30 EST - accessnewswire.com
    LEGN ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Legend Biotech Corporation Shareholders Who Lost Money
    NEW YORK, NY / ACCESS Newswire / June 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Legend Biotech Corporation ("Legend Biotech Corporation") (NASDAQ:LEGN) concerning possible violations of federal securities laws. On May 13, 2024, Legend published first...
    06/04 18:10 EST - youtube.com
    Mizuho's Jared Holz details potential biotech, pharma acquisitions
    Mizuho's Jared Holz joins the 'Fast Money' team to discuss the potential impact of expiring patents within the biotech and pharmaceuticals industries.
    06/03 10:45 EST - globenewswire.com
    Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting
    SOMERSET, N.J., June 03, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today new long-term results from the CARTITUDE-1 study in heavily pretreated relapsed/refractory multiple myeloma (RRMM) patients. RRMM patients...
    05/29 07:25 EST - accessnewswire.com
    LEGN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you Lost Money on your Legend Biotech Corporation Investment
    NEW YORK, NY / ACCESS Newswire / May 29, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Legend Biotech Corporation ("Legend Biotech Corporation") (NASDAQ:LEGN) concerning possible violations of federal securities laws. On May 13, 2024, Legend published first...
    05/28 07:25 EST - accessnewswire.com
    Legend Biotech Corporation Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - LEGN
    NEW YORK, NY / ACCESS Newswire / May 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Legend Biotech Corporation ("Legend Biotech Corporation") (NASDAQ:LEGN) concerning possible violations of federal securities laws. On May 13, 2024, Legend published first...
    05/27 07:25 EST - accessnewswire.com
    Legend Biotech Corporation (LEGN) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
    NEW YORK, NY / ACCESS Newswire / May 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Legend Biotech Corporation ("Legend Biotech Corporation") (NASDAQ:LEGN) concerning possible violations of federal securities laws. On May 13, 2024, Legend published first...
    05/23 07:25 EST - accessnewswire.com
    Shareholder Rights Advocates at Levi & Korsinsky Investigate Legend Biotech Corporation (LEGN) Regarding Possible Securities Fraud Violations
    NEW YORK, NY / ACCESS Newswire / May 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Legend Biotech Corporation ("Legend Biotech Corporation") (NASDAQ:LEGN) concerning possible violations of federal securities laws. On May 13, 2024, Legend published first...
    05/22 17:15 EST - globenewswire.com
    Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT
    SOMERSET, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today that new data evaluating CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) for patients living with multiple myeloma will be presented at the...
    05/21 07:30 EST - accessnewswire.com
    LEGN ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Legend Biotech Corporation
    NEW YORK, NY / ACCESS Newswire / May 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Legend Biotech Corporation ("Legend Biotech Corporation") (NASDAQ:LEGN) concerning possible violations of federal securities laws. On May 13, 2024, Legend published first...
    05/20 07:30 EST - accessnewswire.com
    Legend Biotech Corporation Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - LEGN
    NEW YORK, NY / ACCESS Newswire / May 20, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Legend Biotech Corporation ("Legend Biotech Corporation") (NASDAQ:LEGN) concerning possible violations of federal securities laws. On May 13, 2024, Legend published first...
    05/15 15:45 EST - accessnewswire.com
    LEGN ALERT: Levi & Korsinsky Investigates Legend Biotech Corporation for Possible Securities Fraud Violations
    NEW YORK, NY / ACCESS Newswire / May 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Legend Biotech Corporation ("Legend Biotech Corporation") (NASDAQ:LEGN) concerning possible violations of federal securities laws. On May 13, 2024, Legend published first...
    05/13 11:15 EST - seekingalpha.com
    Legend Biotech Corporation (LEGN) Q1 2025 Earnings Call Transcript
    Legend Biotech Corporation (NASDAQ:LEGN ) Q1 2025 Earnings Conference Call May 13, 2025 8:00 AM ET Company Participants Caroline Paul - Associate Director, IR Ying Huang - Chief Executive Officer Jessie Yeung - Interim Chief Financial Officer Mythili Koneru - Chief Medical Officer Guowei Fang -...
    05/13 07:00 EST - globenewswire.com
    Legend Biotech Reports First Quarter 2025 Results and Recent Highlights
    SOMERSET, N.J., May 13, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today reported its first quarter 2025 unaudited financial results and key corporate highlights.